☰ Chemistry Tree

David J. Riese, Ph.D.

Affiliations:	1997-2010	Medicinal Chemistry and Molecular Pharmacology	Purdue University, West Lafayette, IN, United States
	2010-	Drug Discovery and Development	Auburn University, Auburn, AL, United States

Area:

Cancer Cell Biology, Molecular Biology, and Pharmacology; Cancer Drug Discovery

Website:

http://www.auburn.edu/academic/pharmacy/directory/david-riese.html

Google:

"http://scholar.google.com/citations?user=55j1ZOEAAAAJ&hl=en"

Mean distance: (not calculated yet)

Tree Publications Similar researchers PubMed Report error

Parents

Daniel C. DiMaio	grad student	1987-1993	Yale
David Frederick Stern	post-doc	1993-1997	Yale (Microtree)

Children

Subhrajit Bhattacharya	grad student		(Neurotree)
Desi Penington	grad student	2001	Purdue
Stuart Hobbs	grad student	2004	Purdue
Jennifer Gilmore	grad student	2005	Purdue
Sarah Pitfield	grad student	2006	Purdue
Ianthe Bryant-Gawthrop	grad student	2007	Purdue
Richard M. Gallo	grad student	2007	Purdue
Kristy J. Wilson	grad student	2009	Purdue
Christopher P. Mill	grad student	2011	Purdue
Richard L. Cullum	grad student	2020	Auburn University

Collaborators

Mark A. Lemmon	collaborator		Yale
Jeffrey Settleman	collaborator		Harvard (Cell Biology Tree)

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Cullum RL, Ghosh T, Lucas L, et al. (2019) Abstract 2144: Mutations in ERBB4 may account for clinical resistance of melanomas to inhibitors of the RAS/RAF/MEK/MAPK pathway Cancer Research. 79: 2144-2144
Cullum RL, Lucas LM, Piazza JT, et al. (2018) Abstract A159: Characterization of putative ErbB4 antagonists: targeted melanoma drug discovery Molecular Cancer Therapeutics. 17
Cullum RL, Piazza JT, Senfeld JI, et al. (2017) Abstract 1245: Screening methodologies for the discovery of small molecule melanoma therapeutics targeted at the ErbB4 receptor tyrosine kinase Cancer Research. 77: 1245-1245
Cullum R, David A, Riese DJ. (2016) Abstract 1353: Validation and implementation of screens for partial agonists and antagonists of the ErbB4/HER4 receptor tyrosine kinase: Targeted melanona drug discovery Cancer Research. 76: 1353-1353
Kanthala S, Mill CP, Riese DJ, et al. (2015) Expression And Purification Of HER2 Extracellular Domain Proteins In Schneider2 Insect Cells. Protein Expression and Purification
Cullum RL, Gupta RB, Riese DJ. (2015) Abstract B17: A high-throughput screening process for the discovery of melanoma chemotherapeutics targeted at the ErbB4 receptor tyrosine kinase Cancer Research. 75
Riese DJ, Cullum RL. (2014) Epiregulin: roles in normal physiology and cancer. Seminars in Cell & Developmental Biology. 28: 49-56
Gallo RM, Bryant IN, Mill CP, et al. (2013) Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant. Journal of Cancer Research and Therapeutic Oncology. 1: 10
Allen RE, Copeland J, Franks AS, et al. (2013) Team-based learning in US colleges and schools of pharmacy. American Journal of Pharmaceutical Education. 77: 115
Nickerson NK, Mill CP, Wu HJ, et al. (2013) Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo. Oncology Research. 20: 303-17

See more...